Although IL-15 does not directly contribute to cancer cachexia pathogenesis, the increase in these cells may lead to an augmented immune response associated with IL-15 and potentially serve as a promising biomarker in the treatment of cancer cachexia. The gene discussed is IL15; the disease is cancer.